Emerging therapies for the treatment of wet age-related macular degeneration – VEGF Trap-Eye

Robert Rejdak; Małgorzata Szkaradek; Paweł Grieb; Anselm G.M. Jünemann

eISSN: 2719-3209
ISSN: 0023-2157

Klinika Oczna / Acta Ophthalmologica Polonica

Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

4/2011
vol. 113

Send email

Copy url:

abstract:

Review paper

Emerging therapies for the treatment of wet age-related macular degeneration – VEGF Trap-Eye

Robert Rejdak

^{1, 2, 3}

,

Małgorzata Szkaradek

²

,

Paweł Grieb

³

,

Anselm G.M. Jünemann

⁴

Department of Ophthalmology, Medical University of Lublin, Lublin, Poland
Departament of Ophthalmology, F. Chopin Specialised Hospital in Rzeszów, Rzeszów, Poland
Department of Experimental Pharmacology, Mossakowski Medical Research Centre, Polish Academy of Science, Warsaw, Poland
Department of Ophthalmology and Eye Hospital, Friedrich-Alexander-University of Erlangen-Nurnberg, Erlangen, Niemcy

Klinika Oczna 2011, 113 (4): 376-378

Online publish date: 2011/12/04

View full text Get citation

Age-related macular degeneration (AMD) is the leading cause of blindness in the industrialized world. The most severe form of this disease is exudative AMD. It accounts for 10% of cases of AMD and is responsible for approximately 90% cases of severe vision loss due to AMD. Anti-vascular endothelial growth factor (VEGF) therapy changed the standard-of-care for this blinding disease. This article presents one promising new drug for the treatment of exudative AMD – VEGF Trap-Eye.

keywords:

Emerging therapies for the treatment of wet age-related macular degeneration – VEGF Trap-Eye

Robert Rejdak 1, 2, 3 , Małgorzata Szkaradek 2 , Paweł Grieb 3 , Anselm G.M. Jünemann 4

wet age-related macular degeneration, vascular endothelial growth factor, VEGF Trap-Eye, choroidal neovascularization

Robert Rejdak

^{1, 2, 3}

,

Małgorzata Szkaradek

²

,

Paweł Grieb

³

,

Anselm G.M. Jünemann

⁴